Royal Bank of Canada’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.31M | Buy |
154,059
+68,606
| +80% | +$457K | ﹤0.01% | 3651 |
|
|
2026
Q1 | $465K | Sell |
85,453
-17,755
| -17% | -$99.6K | ﹤0.01% | 4201 |
|
|
2025
Q4 | $722K | Sell |
103,208
-23,778
| -19% | -$186K | ﹤0.01% | 3889 |
|
|
2025
Q3 | $982K | Sell |
126,986
-21,884
| -15% | -$171K | ﹤0.01% | 4006 |
|
|
2025
Q2 | $1.3M | Sell |
148,870
-87,601
| -37% | -$635K | ﹤0.01% | 3670 |
|
|
2025
Q1 | $1.88M | Sell |
236,471
-111,946
| -32% | -$1.13M | ﹤0.01% | 2986 |
|
|
2024
Q4 | $3.17M | Sell |
348,417
-200,194
| -36% | -$1.93M | ﹤0.01% | 2676 |
|
|
2024
Q3 | $5.04M | Sell |
548,611
-47,390
| -8% | -$392K | ﹤0.01% | 2273 |
|
|
2024
Q2 | $5.83M | Sell |
596,001
-38,781
| -6% | -$473K | ﹤0.01% | 2058 |
|
|
2024
Q1 | $9.59M | Sell |
634,782
-65,639
| -9% | -$1.19M | ﹤0.01% | 1706 |
|
|
2023
Q4 | $15.1M | Sell |
700,421
-104,085
| -13% | -$1.92M | ﹤0.01% | 1450 |
|
|
2023
Q3 | $15M | Buy |
804,506
+152,213
| +23% | +$3.55M | ﹤0.01% | 1313 |
|
|
2023
Q2 | $16.5M | Buy |
652,293
+311,421
| +91% | +$7.84M | ﹤0.01% | 1263 |
|
|
2023
Q1 | $8.83M | Sell |
340,872
-201,603
| -37% | -$5.4M | ﹤0.01% | 1644 |
|
|
2022
Q4 | $12.8M | Buy |
542,475
+48,102
| +10% | +$1.3M | ﹤0.01% | 1447 |
|
|
2022
Q3 | $12.5M | Sell |
494,373
-139,562
| -22% | -$4.9M | ﹤0.01% | 1381 |
|
|
2022
Q2 | $21.1M | Sell |
633,935
-266,948
| -30% | -$11.3M | 0.01% | 1078 |
|
|
2022
Q1 | $65M | Buy |
900,883
+65,247
| +8% | +$4.7M | 0.02% | 652 |
|
|
2021
Q4 | $76.7M | Buy |
835,636
+94,206
| +13% | +$11.3M | 0.02% | 623 |
|
|
2021
Q3 | $94M | Buy |
741,430
+61,917
| +9% | +$9.01M | 0.02% | 507 |
|
|
2021
Q2 | $113M | Buy |
679,513
+1,158
| +0.2% | +$188K | 0.03% | 452 |
|
|
2021
Q1 | $123M | Sell |
678,355
-8,720
| -1% | -$2.02M | 0.04% | 400 |
|
|
2020
Q4 | $137M | Buy |
687,075
+129,047
| +23% | +$26.2M | 0.04% | 372 |
|
|
2020
Q3 | $122M | Buy |
558,028
+117,721
| +27% | +$24.9M | 0.04% | 338 |
|
|
2020
Q2 | $84M | Buy |
440,307
+57,746
| +15% | +$10.1M | 0.03% | 413 |
|
|
2020
Q1 | $59.3M | Buy |
382,561
+71,606
| +23% | +$8.33M | 0.03% | 459 |
|
|
2019
Q4 | $26M | Buy |
310,955
+119,644
| +63% | +$9.1M | 0.01% | 990 |
|
|
2019
Q3 | $13M | Sell |
191,311
-84,694
| -31% | -$5.57M | 0.01% | 1361 |
|
|
2019
Q2 | $18.3M | Buy |
276,005
+79,547
| +40% | +$4.64M | 0.01% | 1159 |
|
|
2019
Q1 | $10.9M | Sell |
196,458
-36,436
| -16% | -$2.22M | ﹤0.01% | 1463 |
|
|
2018
Q4 | $11.5M | Buy |
232,894
+157,774
| +210% | +$9.65M | 0.01% | 1359 |
|
|
2018
Q3 | $6.49M | Buy |
75,120
+8,196
| +12% | +$584K | ﹤0.01% | 1926 |
|
|
2018
Q2 | $3.88M | Buy |
66,924
+2,653
| +4% | +$130K | ﹤0.01% | 2200 |
|
|
2018
Q1 | $2.59M | Buy |
64,271
+38,043
| +145% | +$1.44M | ﹤0.01% | 2481 |
|
|
2017
Q4 | $915K | Buy |
26,228
+5,572
| +27% | +$185K | ﹤0.01% | 3299 |
|
|
2017
Q3 | $685K | Buy |
20,656
+4,285
| +26% | +$140K | ﹤0.01% | 3550 |
|
|
2017
Q2 | $568K | Sell |
16,371
-1,015
| -6% | -$29.6K | ﹤0.01% | 3569 |
|
|
2017
Q1 | $435K | Buy |
17,386
+7,946
| +84% | +$165K | ﹤0.01% | 3751 |
|
|
2016
Q4 | $155K | Buy |
9,440
+2,996
| +46% | +$50.9K | ﹤0.01% | 4632 |
|
|
2016
Q3 | $118K | Buy |
6,444
+458
| +8% | +$8.03K | ﹤0.01% | 4734 |
|
|
2016
Q2 | $96K | Buy |
5,986
+2,586
| +76% | +$30.2K | ﹤0.01% | 4806 |
|
|
2016
Q1 | $33K | Sell |
3,400
-2,269
| -40% | -$32.2K | ﹤0.01% | 5301 |
|
|
2015
Q4 | $102K | Buy |
5,669
+3,644
| +180% | +$67.3K | ﹤0.01% | 4922 |
|
|
2015
Q3 | $45K | Buy |
+2,025
| New | +$54.7K | ﹤0.01% | 5191 |
|
Other funds holding TDOC
VC
Royal Bank of Canada's TDOC Position: Q2 2026 in Review
Royal Bank of Canada increased its Teladoc Health (TDOC) stake by 80% in Q2 2026, buying an estimated $457K and bringing the position to 154,059 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #3651.
Royal Bank of Canada first reported a position in TDOC in Q3 2015 and has held it in 44 quarters since. The position peaked at $137M in Q4 2020. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.
- Royal Bank of Canada held 154,059 shares of Teladoc Health worth $1.31M as of Q2 2026.
- Royal Bank of Canada bought 68,606 Teladoc Health shares in Q2 2026, an estimated $457K.
- Teladoc Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #3651 holding.
- Royal Bank of Canada first reported a position in Teladoc Health in Q3 2015 and has held it in 44 quarters since.
- Royal Bank of Canada's Teladoc Health position peaked at $137M in Q4 2020.
- 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.